Neurocrine Biosciences, Inc. (NBIX)
154.75
-0.88
(-0.57%)
USD |
NASDAQ |
Dec 11, 16:00
154.66
-0.09
(-0.06%)
After-Hours: 20:00
Neurocrine Biosciences Total Liabilities (Quarterly): 1.262B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 115.64B |
| Align Technology, Inc. | 2.276B |
| Hologic, Inc. | 3.967B |
| Masimo Corp. | 1.008B |
| Insulet Corp. | 1.645B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.266B |
| Shareholders Equity (Quarterly) | 3.004B |
| Debt to Equity Ratio | 0.1597 |
| Current Ratio | 3.383 |
| Net Debt Paydown Yield | -0.27% |